About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials in Phoenix | 81 Studies

Clinical Trials DepressionPhoenix

Depression Clinical Trials in Phoenix

Find 81 clinical trials for depression near Phoenix, Arizona. Connect with research centers in your area.

All Depression trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 81 trials

CompletedLong-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000, in participants with Major Depressive Disorder (MDD).NCT06423781·Chandler, Arizona and 65 others

Depression Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Clinical Trial of PRAX-114 in Participants With Major Depressive DisorderThis is a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of PRAX-114 in participants with moderate to severe major depressive…NCT04832425·Phoenix, Arizona and 30 others

CompletedA Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)The purpose of this study is to evaluate sleep in participants with Major Depressive Disorder with moderate to severe insomnia symptoms (MDDIS) or MDD with no or mild insomnia…NCT07258485·Phoenix, Arizona and 22 others

CompletedARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentThis multi-center, randomized, double-blind, placebo-controlled, parallel-group study will investigate the efficacy and safety of RO4995819 as adjunctive therapy in patients with…NCT01457677·Phoenix, Arizona and 91 others

CompletedLong-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive DisorderThis study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).NCT03002077·Birmingham, Alabama and 127 others

CompletedActive Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)Investigation of the efficacy and safety of a new potential treatment of Major depressive disorder (MDD) in paediatric participants (age 7 to 11 years).NCT02709655·Little Rock, Arkansas and 97 others

RecruitingEvaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderThe purpose of this study is to determine the efficacy and safety of milsaperidone compared to placebo as adjunctive therapy in patients with Major Depressive DisorderNCT06830044·Phoenix, Arizona and 52 others

TerminatedA Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and PsychotherapyThe purpose of this study is to assess the safety and tolerability of Seltorexant as adjunctive therapy to an antidepressant in adolescents with major depressive disorder (MDD) in…NCT04951609·Phoenix, Arizona and 22 others

CompletedA Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive DisorderThis study will evaluate the efficacy, safety and tolerability of rapastinel 450 milligrams (mg) intravenous (IV) once weekly or once every 2 weeks versus placebo as an adjunctive…NCT02951988·Birmingham, Alabama and 136 others

TerminatedStudy to Assess the Safety and Effectiveness of NMRA-335140-501This is a 52-week open-label extension (OLE) study that will evaluate the safety, tolerability, and effectiveness of NMRA-335140 in participants with major depressive disorder…NCT06029439·Huntsville, Alabama and 177 others

CompletedSexual Functioning Study With AntidepressantsEffects of two depression medication on sexual functioningNCT00316160·Mesa, Arizona and 44 others

CompletedA Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant TherapyThe purpose of this study is to assess the efficacy of flexibly dosed JNJ-42847922 (20 milligram \[mg\] or 40 mg) compared to flexibly dosed quetiapine extended-release (XR) (150…NCT03321526·Phoenix, Arizona and 49 others

Enrolling by invitationAn Open-Label Study of Azetukalner in Major Depressive DisorderX-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult participants who successfully…NCT06922110·Phoenix, Arizona and 70 others

CompletedVortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)The purpose of this study is to evaluate the efficacy of vortioxetine (5, 10, and 20 mg) versus placebo during the first 28 weeks of the 32-week double-blind treatment period in…NCT02371980·Phoenix, Arizona and 78 others

CompletedEfficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneThe objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who…NCT03738215·Phoenix, Arizona and 124 others

UnknownEvaluation of Programs of Coordinated Care and Disease ManagementThis is a Congressionally mandated study.NCT00627029·Phoenix, Arizona and 14 others

CompletedStudy in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs PlaceboA proof of concept (POC) study evaluating the impact of NMRA-335140 (BTRX-335140) relative to placebo on symptoms of major depressive disorder (MDD) in adult participants with MDD…NCT04221230·Phoenix, Arizona and 37 others

CompletedClinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in patients with a primary diagnosis of MDD according to criteria of the…NCT04985942·Phoenix, Arizona and 53 others

CompletedA Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive DisorderThis is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.NCT06254612·Phoenix, Arizona and 49 others

Enrolling by invitationPhase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)This is a long- term extension of the double-blind trials APPROACH (CYB003-002) and EMBRACE (CYB003-003).NCT06605105·Phoenix, Arizona and 48 others

PreviousPage 2 of 5Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia